Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Is It Time To Revisit Abbott Laboratories (ABT) After Recent Share Price Weakness?
Abbott Laboratories (ABT) is currently priced at US$112.65 and is assessed as potentially undervalued based on a Discounted Cash Flow (DCF) analysis, which suggests a 27.4% discount to its intrinsic value of $155.09 per share. The stock’s P/E ratio of 30.12x is above the Medical Equipment industry average, but below its peer group and Simply Wall St’s proprietary “Fair Ratio” of 40.50x, also indicating potential undervaluation. Investors are encouraged to use “Narratives” to customize valuation based on individual assumptions for a more personalized analysis.